📊 Market Growth Overview
The global Atherosclerosis Drugs Market was valued at approximately USD 20.6 billion in 2022, and is projected to reach USD 27.7 billion by 2032, growing at a CAGR of around 3.0 % from 2023 to 2032 .
A separate study by Acumen Research & Consulting forecasts growth from USD 20.5 billion in 2022 to USD 26.9 billion by 2032, implying a similar CAGR of about 2.8 % ....
The atherosclerosis drugs market is currently experiencing significant transformations, driven by an increasing prevalence of cardiovascular diseases (CVDs) globally. As one of the leading causes of death worldwide, atherosclerosis – the condition where plaque builds up inside the arteries – has become a focal point for pharmaceutical companies. The market is competitive, with...
The atherosclerosis drugs market is one of the most dynamic sectors within the global pharmaceutical industry. As the prevalence of cardiovascular diseases continues to rise, driven by factors such as aging populations, sedentary lifestyles, and increasing rates of obesity and diabetes, the demand for effective atherosclerosis treatments is set to grow significantly. This article delves into...
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek